SPRAVATO®
A New Path Forward
An in-office treatment option for eligible adults with treatment-resistant depression.

Treatment Resistant Depression
For adults who have not had enough improvement with traditional antidepressant treatment.
In Office Monitoring
Treatment is administered in office with required
monitoring
Evaluation Required
A provider will review your history. medications. safety considerations, and eligibility.
Insurance Coverage
Coverage depends on your plan requirements.
benefits, and authorization.
What to Expect
Important Safety Information
-
Plan for monitored treatment: SPRAVATO® is administered under medical supervision, with monitoring for at least two hours after each dose and until you are cleared to leave.
-
Prepare for your appointment: Avoid food for at least two hours and liquids for at least 30 minutes before treatment to help reduce nausea and vomiting.
-
Arrange a ride home: Do not drive, operate machinery, or perform activities requiring full alertness until the next day after a restful sleep.
Evaluation
Review symptoms, history, diagnosis, medications,
and eligibility
Authorization
Our team helps determine coverage and next steps.
Treatment
Administered in office only under strict monitoring.
Plan
Frequency and ongoing treatments are based on response and appropriateness

Hope changes everything

